0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Reproducibility of Spectral-Domain Optical Coherence Tomography Retinal Thickness Measurements and Conversion to Equivalent Time-Domain Metrics in Diabetic Macular Edema

JAMA Ophthalmol. 2014;132(9):1113-1122. doi:10.1001/jamaophthalmol.2014.1698.
Text Size: A A A
Published online

Importance  Understanding measurement variability and relationships between measurements obtained on different optical coherence tomography (OCT) machines is critical for clinical trials and clinical settings.

Objective  To evaluate the reproducibility of retinal thickness measurements from OCT images obtained by time-domain (TD) (Stratus; Carl Zeiss Meditec) and spectral-domain (SD) (Cirrus; Carl Zeiss Meditec, and Spectralis; Heidelberg Engineering) instruments and formulate equations to convert retinal thickness measurements from SD-OCT to equivalent values on TD-OCT.

Design, Setting, and Participants  A cross-sectional observational study was conducted in private and institutional practices. Persons with diabetes mellitus who had at least 1 eye with central-involved diabetic macular edema, defined as Stratus central subfield thickness (CST) of 250 μm or greater, participated. An additional normative cohort (individuals with diabetes but without diabetic macular edema) was enrolled. Each study eye underwent 2 replicate Stratus scans followed by 2 replicate Cirrus or Spectralis scans (real-time image registration used) centered on the fovea.

Main Outcomes and Measures  Optical coherence tomography CST and macular volume.

Results  The Bland-Altman coefficient of repeatability for relative change in CST (the degree of change that could be expected from measurement variability) was lower with Spectralis (7%) compared with Cirrus (14%) and Stratus (12% and 15% within Cirrus/Stratus and Spectralis/Stratus groups, respectively). For each cohort, the initial Stratus CST was within 10% of the replicate Stratus measurement nearly all of the time; the conversion equations predicted a Stratus CST within 10% of the observed thickness 86% and 89% of the time for Cirrus/Stratus and Spectralis/Stratus groups, respectively, which is similar to the agreement on Stratus test-retest. The Bland-Altman limits of agreement for relative change in CST between machines (the degree of change that could be expected from measurement variability [combining within and between instrument variability]) were 21% for Cirrus and 19% for Spectralis when comparing predicted vs actual Stratus measurement.

Conclusions and Relevance  Reproducibility appears to be better with Spectralis than with Cirrus and Stratus. Conversion equations to transform Cirrus or Spectralis measurements to Stratus-equivalent values, within 10% of the observed Stratus thickness values, appear feasible. Central subfield thickness changes beyond 10% when using the same machine or 20% when switching machines, after conversion to Stratus equivalents, are likely due to a change in retinal thickness rather than measurement error.

Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Place holder to copy figure label and caption
Figure 1.
Bland-Altman Plots of the Differences vs the Means of the Automated Central Subfield Thickness (CST) Test-Retest Values

A, Stratus results within the Cirrus/Stratus group (n = 531). B, Cirrus results within the Cirrus/Stratus group (n = 531). C, Stratus results within the Spectralis/Stratus primary cohort (n = 429). D, Spectralis results within the Spectralis/Stratus primary cohort (n = 429). E, Stratus results within the Spectralis/Stratus normative cohort (n = 288). F, Spectralis results within the Spectralis/Stratus normative cohort (n = 288). Solid reference lines indicate mean difference; dashed lines indicate the limits of agreement.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Bland-Altman Plots of the Machine Differences (Spectral Domain Minus Stratus) vs the Automated Stratus Test-Retest Means

A, Central subfield thickness (CST) results within the Cirrus/Stratus group (n = 479). B, CST results within the Spectralis/Stratus group (n = 689). C, Retinal volume results within the Cirrus/Stratus group (n = 420). D, Retinal volume results within the Spectralis/Stratus group (n = 632). Solid reference lines indicate mean difference; dashed lines indicate the limits of agreement.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.
Bland-Altman Plots of the Relative (%) Differences Between the Predicted Stratus Value (Using the Conversion Equation) Minus the Observed Stratus Value

A, Central subfield thickness (CST) results within the Cirrus/Stratus group (n = 272). B, CST results within the Spectralis/Stratus group (n = 375). C, Retinal volume results within the Cirrus/Stratus group (n = 253). D, Retinal volume results within the Spectralis/Stratus group (n = 381). Solid reference lines indicate mean difference; dashed lines indicate the limits of agreement.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();